Risk factors for hyperkalaemia in a cohort of patients with newly diagnosed heart failure: a nested case-control study in UK general practice
Author:
Affiliation:
1. Bayer Pharma AG, Global Epidemiology; Berlin Germany
2. Spanish Centre for Pharmacoepidemiologic Research (CEIFE); Madrid Spain
Funder
Bayer Pharma AG
Publisher
Wiley
Subject
Cardiology and Cardiovascular Medicine
Reference30 articles.
1. Hyperkalaemia;Nyirenda;BMJ,2009
2. Hyperkalemia associated with inhibitors of the renin-angiotensin-aldosterone system: balancing risk and benefit;Desai;Circulation,2008
3. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC;McMurray;Eur J Heart Fail,2012
4. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators;Pitt;N Engl J Med,1999
5. Rates of hyperkalemia after publication of the Randomized Aldactone Evaluation Study;Juurlink;N Engl J Med,2004
Cited by 62 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Management of Hyperkalemia in Renin-Angiotensin-Aldosterone System Inhibitor: Strategies to Maintain Chronic Kidney Disease Patients with Type II Diabetes on Therapy;Cardiorenal Medicine;2024
2. Changes in serum potassium with concomitant administration of renin-angiotensin system agents and potassium-sparing diuretics: U.S. cohort study using electronic health record data;JAPhA Pharmacotherapy;2024-01
3. Sizing SGLT2 Inhibitors Up: From a Molecular to a Morpho-Functional Point of View;International Journal of Molecular Sciences;2023-09-08
4. Impact of Hyperkalemia in Heart Failure and Reduced Ejection Fraction: A Retrospective Study;Journal of Clinical Medicine;2023-05-22
5. Pleiotropic Effects of Sodium-Glucose Cotransporter-2 Inhibitors in Cardiovascular Disease and Chronic Kidney Disease;Journal of Clinical Medicine;2023-04-12
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3